Molecular and Precision Medicine (MAP) Series

Complete Video Program


April 21, 2021

Pancancer Analysis of Whole Genomes

Gad Getz, PhD
Broad Institute/MGH Cancer Center

Kinase Pathway Targeted Therapeutics

Keith T. Flaherty, MD
MGH Cancer Center/Harvard Medical School

Moderator

Aditya Bardia, MD, MPH
Massachusetts General Hospital Cancer Center, Harvard Medical School


April 28, 2021

Genotyping Techniques and Reports

Geoff R. Oxnard, MD
Foundation Medicine

Germline and Ethical Considerations

Leif W. Ellisen, MD, PhD
MGH Cancer Center/Harvard Medical School

Moderator

Jochen Lennerz, MD
Center for Integrated Diagnostics, Massachusetts General Hospital


May 5, 2021

Targeting PI3K Pathway

Dejan Juric, MD
MGH/Termeer Center for Targeted Therapies

Plasma vs Tissue Genotyping: Debate

(Pro Tissue – Dr. Iafrate; Pro Plasma – Dr. Corcoran)
A. John Iafrate, MD
MGH/Harvard Medical School
Ryan B. Corcoran, MD, PhD
MGH Cancer Center/Harvard Medical School

Moderator

Aparna Parikh, MD, MS
Termeer Center for Targeted Therapies, Massachusetts General Hospital Cancer Center


May 12, 2021

Targeting ALK, ROS and Other Fusion Drivers

Alice T. Shaw, MD, PhD
Novartis

Targeting MET

Rebecca S. Heist, MD, MPH
MGH/Harvard Medical School

Moderator

Aaron Hata, MD, PhD
Massachusetts General Hospital


May 19, 2021

Role of Immunotherapy in the Era of Precision Medicine

Justin F. Gainor, MD
MGH Cancer Center/Harvard Medical School

Role of Antibody Drug Conjugates in the Era of Precision Medicine

David R. Spriggs, MD
MGH Cancer Center/Harvard Medical School

Moderator

Ryan J. Sullivan, MD
Massachusetts General Hospital Cancer Center



Privacy Policy | Terms of Use | Contact Us

Society for Translational Oncology (STO) is a 501(c)(3) not-for-profit organization.